Philip Morris International Inc

Big names in pharma and biotech also report earnings, and labor data to come on Friday.

We take a look at the yield-rich utilities sector, Big Tobacco, and the major integrated oil group.

The industry is facing some disruption, but core cigarette businesses continue to perform.

There were fewer opportunities as the third quarter ended.

The new earnings season kicks off with names from a variety of sectors.

These stocks have a wide or narrow economic moat and an uncertainty rating of low or medium.

Potential vaping regulations have limited impact on our valuations.

We find several actionable ideas that yield more than the S&P 500.

We're expecting earnings results from Adobe as well as the Datadog IPO.

The moats of these 14 large-cap companies may be wide, but they’re deteriorating.

As earnings season slows down, we're watching for the Fed's Beige Book release and tariffs on Chinese goods.

We think a PMI-Altria merger makes a lot of strategic sense.

During the first quarter, impressive stock-selection was offset by overweighted sector exposures.

Seven of the top 10 dividend-yielding names are undervalued.

Bronze-rated Columbia Contrarian Core buys companies trading with heightened pessimism that have catalysts in place to lift sentiment.

We are reiterating our fair value estimate and our wide economic moat rating for the firm.

We see opportunity in Phillip Morris International and British American Tobacco.

These low- and medium-uncertainty stocks are trading at the largest discounts to our fair value estimates.

These dividend payers all carry wide moats, yield more than 5%, and trade in 4- and 5-star range.

Large-cap growth and large-cap value strategies maintain gains above index, market is undervalued.